Joseph Slattery


Mr. Slattery currently serves as Executive Vice President and Chief Financial Officer of TransEnterix, Inc. (TRXC), a medical device company. Most recently, Mr. Slattery served as executive vice president and CFO at Baxano Surgical Inc., a minimally invasive spinal surgery company. Previously, he served as CFO and senior vice president of finance and information systems of Digene Corp., a molecular diagnostics company acquired by Qiagen, N.V. Currently, he serves on the boards of directors of CVRx Inc., Exosome Diagnostics, Inc., and Replimune Group, Inc. Mr. Slattery earned his bachelor’s degree in accountancy from Bentley University and is a certified public accountant.